Global Growth Companies With Insider Ownership Up To 37%

Simply Wall St

As global markets continue to navigate a landscape of record highs and evolving trade dynamics, investors are keeping a close eye on the interplay between inflation trends and economic growth. Amidst this backdrop, companies that exhibit robust growth potential coupled with significant insider ownership often stand out as compelling opportunities, reflecting confidence from those closest to the business.

Top 10 Growth Companies With High Insider Ownership Globally

NameInsider OwnershipEarnings Growth
Zhejiang Leapmotor Technology (SEHK:9863)15.6%59.9%
Suzhou Sunmun Technology (SZSE:300522)35.4%77.7%
Shanghai Huace Navigation Technology (SZSE:300627)24.3%23.5%
Samyang Foods (KOSE:A003230)11.7%24.3%
Pharma Mar (BME:PHM)11.8%44.9%
Laopu Gold (SEHK:6181)35.5%40.5%
KebNi (OM:KEBNI B)38.3%66.2%
Fulin Precision (SZSE:300432)13.6%43.7%
Elliptic Laboratories (OB:ELABS)24.4%79%
Bergen Carbon Solutions (OB:BCS)12%63.2%

Click here to see the full list of 833 stocks from our Fast Growing Global Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Partners Group Holding (SWX:PGHN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Partners Group Holding AG is a private equity firm that specializes in direct, secondary, and primary investments across private equity, real estate, infrastructure, and debt with a market cap of CHF26.68 billion.

Operations: The company's revenue segments include CHF1.34 billion from Private Equity, CHF390.70 million from Infrastructure, CHF207.70 million from Private Credit, and CHF182.10 million from Real Estate.

Insider Ownership: 17.2%

Partners Group Holding is expanding in the Middle East with a new Abu Dhabi office and strengthening its US private wealth business with key leadership hires. Despite moderate revenue growth forecasts of 13.2% annually, outpacing the Swiss market, its earnings are expected to grow at 11.83% per year. The company faces challenges with high debt levels and a dividend not fully covered by earnings or cash flows, but it trades below estimated fair value and has a very high forecasted return on equity of 51.3%.

SWX:PGHN Ownership Breakdown as at Jun 2025

AcrobiosystemsLtd (SZSE:301080)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Acrobiosystems Co., Ltd. develops and manufactures recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies as well as scientific research institutions, with a market cap of CN¥7.33 billion.

Operations: The company's revenue primarily comes from Research and Experimental Development, amounting to CN¥673.43 million.

Insider Ownership: 37.3%

Acrobiosystems Ltd. is poised for significant growth, with earnings projected to increase by 23.42% annually, surpassing the Chinese market's average. Despite a volatile share price and a low forecasted return on equity of 7.8%, it trades at 21.7% below its estimated fair value, indicating potential undervaluation. Recent financials show improved quarterly revenue and net income compared to last year, although dividends remain unsustainable from free cash flows and insider trading activity is minimal.

SZSE:301080 Ownership Breakdown as at Jun 2025

Gold Circuit Electronics (TWSE:2368)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Gold Circuit Electronics Ltd. is a Taiwanese company that designs, manufactures, processes, and distributes printed circuit boards with a market cap of NT$134.33 billion.

Operations: The company's revenue is primarily derived from the manufacturing and sales of printed circuit boards, amounting to NT$41.95 billion.

Insider Ownership: 31.4%

Gold Circuit Electronics demonstrates robust growth potential with earnings expected to rise significantly at 22.2% annually, outpacing the Taiwan market. Despite high share price volatility, it trades at 17% below its fair value estimate. Recent financials reveal a strong performance with first-quarter sales reaching TWD 12.06 billion and net income of TWD 1.75 billion, reflecting substantial year-over-year growth, although dividends remain inadequately covered by free cash flows.

TWSE:2368 Ownership Breakdown as at Jun 2025

Seize The Opportunity

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if AcrobiosystemsLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com